Relationship between prior inhaled corticosteroid use and benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related quality of life, and lung function in patients with chronic obstructive pulmonary disease: Analyses from the ETHOS study-Reference-Cited by-同舟云学术

Relationship between prior inhaled corticosteroid use and benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related quality of life, and lung function in patients with chronic obstructive pulmonary disease: Analyses from the ETHOS study

Published:2022-06 Issue: Volume:197 Page:106857
ISSN:0954-6111
Container-title:Respiratory Medicine
language:en
Short-container-title:Respiratory Medicine

Author:

Singh Dave,Rabe Klaus F.,Martinez Fernando J.^ORCID,Krüll Matthias,Jenkins Martin,Patel Mehul,Dorinsky Paul^ORCID

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference19 articles.

1. Triple inhaled therapy at two glucocorticoid doses in moderate-to-very-severe COPD;Rabe;N. Engl. J. Med.,2020

2. Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial

3. Once-daily single-inhaler triple versus dual therapy in patients with COPD;Lipson;N. Engl. J. Med.,2018

4. Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial;Papi;Lancet,2018

5. Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial;Singh;Lancet,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history;Respiratory Research;2024-08-05

2. COUNTERPOINT: Should Triple Inhaled Therapy Be Considered in All Patients With Group E COPD? No;CHEST;2024-07

3. Rebuttal From Dr Suissa;CHEST;2024-07

4. Mortality of patients with COPD;Expert Review of Respiratory Medicine;2024-06-02

5. Comparing Glycopyrronium/Formoterol Combination Therapy With Monotherapy in Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD): A Narrative Review;Cureus;2024-04-20